Success Stories: Postdoctoral Fellow in Massachusetts in the Field of Nanomedicine Has EB-1A Approved
Client’s Testimonial:
Great news!! It has been a great pleasure to have your professional service for my I-140 application. It was a fantastic experience, and I would highly recommend your firm!
Position at the Time of Case Filing: Postdoctoral Fellow
Country of Origin: China
Service Center: Texas Service Center (TSC)
State of Residence at the Time of Filing: Massachusetts
Approval Notice Date: May 28, 2014
Processing Time: 1 month, 4 days (12 days after requesting Premium Processing)
In this case, the client that we had the pleasure of working with was a Postdoctoral Fellow from China in the field of Nanomedicine. His specialized research had focused on applying nanotechnology to the development of new medicines and therapies for treatment of various kinds of cancers. His work had resulted in 12 peer-reviewed scientific articles and numerous presentations at national and international conferences. At the time that his case was filed, his publications had been cited at least 317 times by independent and leading researchers from prestigious institutions and organizations around the world, indicating the major significance of his work. He had also reviewed more than 30 manuscripts for distinctive, internationally-circulated journals. The significance of his research was confirmed in the following quote from an independent recommender, “Platform technology such as that employed in the creation of [his] nanomedicines carrier can be engineered for application in treatment of various other diseases: all that is required is switching the drug within the carrier, the siRNA target, and the surface particles that target the tumor. This methodology is currently being tested by [him] in more complex TNBC models as well as for adaptation to treat ovarian, bone, and lung cancers. All these are among the highest causes of cancer death in the United States, and creating an adaptable drug delivery vehicle for targeting these kinds of cancers is wildly important in the battle against cancer as a whole.” It was our goal to prove that our client qualified for classification as an Alien of Extraordinary Ability given that he sought remain in the United States to continue work in the area of extraordinary ability, and that his continued research would substantially and prospectively benefit the United States. With the proof and documentation that we provided, his case was approved in 1 month and 4 days.